Re-thinking the possible interaction between proton pump inhibitors and capecitabine Soo Hee JeongLara MolloyNuala Helsby Review Article Open access 13 September 2022 Pages: 381 - 388
Introducing a simple and cost-effective RT-PCR protocol for detection of DPYD*2A polymorphism: the first study in Kurdish population Mohammad SalmaniBayazid GhaderiMohammad Abdi Original Article 09 September 2022 Pages: 389 - 397
Population pharmacokinetics of zanidatamab, an anti-HER2 biparatopic antibody, in patients with advanced or metastatic cancer Jeffrey R. ProctorElaina M. GartnerRupert H. Davies Original Article 14 September 2022 Pages: 399 - 408
The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects Ting LiXin LiYu Cao Original Article Open access 15 September 2022 Pages: 409 - 415
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine–cisplatin treatment Karlijn VerkerkHans-Martin OttenAlwin D. R. Huitema Short Communication 20 September 2022 Pages: 417 - 419
Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review Takuya KanekoKosuke DokiMasato Homma Short Communication 30 September 2022 Pages: 421 - 426
Effects of vitamin E in preventing taxane‑induced peripheral neuropathy Shima HeidariMona Kargar Letter to the Editor 05 October 2022 Pages: 427 - 428
The use of vitamin E in preventing taxane‐induced peripheral neuropathy Muhammad Ali HeibaSoheir Sayed IsmailKhaled Abdel-Aziz Kamal Letter to the Editor 05 October 2022 Pages: 429 - 430